Diabetes and cardiometabolic companies need credibility and press to grow, yet the category draws scrutiny from journalists, regulators, and clinicians as soon as a claim exceeds the evidence. We run PR that earns coverage through real substance, strengthens clinical credibility, and keeps a crisis plan ready – so the story helps you rather than harms you.
The Challenge
Your press release overreaches and attracts precisely the scrutiny you cannot withstand
The pressure to sound revolutionary pushes health companies to write claims their evidence does not support, and in cardiometabolic care that gap is precisely what investigative journalists and regulators look for. A splashy but overstated announcement can trigger a takedown story that erases the goodwill it was meant to build. The category has watched high-profile health startups collapse on exactly this dynamic. Credible PR means claiming only what the evidence backs, which is less exciting and far more durable.
Without clinical credibility, journalists and buyers dismiss everything you say
In a field crowded with hype, reporters and sophisticated buyers weigh who is behind the claims and whether real clinicians and evidence stand with the company. Without third-party validation – published data, respected clinical voices, peer recognition – your announcements read as marketing and get ignored or challenged. Cardiometabolic buyers, especially payers and health systems, will not act on unvalidated assertions. Building that credibility is slow, deliberate work that most PR pushes skip in favor of quick hits.
When scrutiny arrives, you lack a crisis plan and every silent hour causes damage
Health companies eventually face a hard question – a data concern, a safety issue, a regulatory inquiry, a critical story – and the ones without a plan improvise badly under pressure. In a trust-based category, a slow or defensive response can do more damage than the original issue. Cardiometabolic companies carry real clinical stakes, so the crisis is a matter of when, not if. Being ready with a plan, spokespeople, and holding statements is the difference between a contained event and a lasting wound.
You pursue vanity placements rather than coverage that influences your buyers
A mention in a general tech outlet feels good and does almost nothing for a company whose buyers are benefits leaders, payers, and clinicians. Vanity coverage burns effort that could have earned a trade or clinical placement your actual buyers read and trust. In cardiometabolic care the audiences that matter consume specific channels, and PR aimed at generic reach misses them entirely. Coverage has to be measured by whether it reaches and persuades the people who decide.
How We Support You
We begin by establishing the claims line. Before conducting any outreach, we collaborate with your clinical and legal teams to determine exactly what you can say and what the evidence supports, then build a newsworthy story within those boundaries. In cardiometabolic PR, this discipline is everything, because an overclaimed story is not a potential win – it is a potential takedown.
Next, we intentionally build clinical credibility. We identify the third-party validation that makes your claims credible – published or presentable data, respected clinical voices, peer recognition – and sequence PR so that credibility comes before the big swing. In a category saturated with hype, this separates announcements that drive action from those that are dismissed.
We then pursue coverage that reaches your real buyers. We identify the outlets and journalists your patients, employers, payers, and clinicians genuinely trust, prioritizing those placements over vanity logos. We develop the narrative and pitch to come across as substance rather than marketing, while building lasting relationships with reporters covering this beat.
For execution, we operate PR as an ongoing motion connected to genuine milestones – clinical results, partnerships, product releases – instead of a string of isolated blasts. We also establish crisis infrastructure in advance: a plan, named spokespeople, and pre-drafted holding statements for the scenarios this category predictably creates, ensuring a difficult day does not turn into an improvised disaster.
For measurement, we monitor credibility and buyer-relevant reach rather than clip counts: coverage in outlets your buyers trust, share of voice versus competitors, and whether that coverage helps sales conversations. PR that produces clips no buyer encounters is ineffective, so we direct efforts toward coverage that works.
Our difference is that we manage PR as embedded operators responsible for both growth potential and risk posture – combining credibility-building and crisis readiness in one motion. In a trust-driven clinical category, earning attention cannot be separated from surviving scrutiny, and we own both.
What we deliver
- Claims line defined with clinical and legal – a newsworthy story built strictly inside what the evidence supports
- Clinical credibility program – third-party validation, clinical voices, and peer recognition sequenced ahead of major announcements
- Buyer-relevant media targeting and journalist relationships across the trade, clinical, and consumer outlets your buyers trust
- Milestone-driven PR motion tied to clinical results, partnerships, and releases rather than disconnected blasts
- Crisis infrastructure – plan, trained spokespeople, and pre-drafted holding statements for the scenarios this category produces
In cardiometabolic health, PR is not about being as loud as possible – it is about how well your story withstands scrutiny. A company that claims only what the evidence supports earns compounding trust; one that overclaims is authoring its own takedown.
Our Methodology
We operate PR through a 90-day sprint followed by an ongoing motion. The opening 30 days focus on foundation: we establish the claims line with clinical and legal, identify the outlets and journalists your buyers trust, and prepare the crisis plan and holding statements before anything is released. Days 30 through 60 center on credibility-building: we sequence third-party validation, develop relationships with key reporters, and frame the narrative around a genuine, defensible milestone. Days 60 through 90 are the earned-coverage push: we pitch the substance to appropriate outlets and instrument buyer-relevant reach and share of voice.
Unlike a traditional PR agency, we take responsibility for risk posture as well as growth. Most agencies pursue clips while treating compliance and crisis as secondary concerns, which is how a win becomes an incident in this category. We set the claims line first, establish credibility ahead of the big swing, and maintain crisis infrastructure – because in health, attracting attention and withstanding scrutiny are one job.
Our Approach
The initial 30 days address foundation and risk. We establish the claims line alongside your clinical and legal teams, map the media landscape your buyers genuinely trust, and create the crisis plan, designate spokespeople, and prepare holding statements. You will gain a clear understanding of what you can credibly say and be ready for the difficult questions this category eventually raises.
Days 30 through 60 focus on credibility and relationships. We sequence third-party validation, develop relationships with reporters covering the cardiometabolic beat, and frame the narrative around a genuine milestone. We collaborate closely with your leadership and clinical voices because credible health PR comes from real evidence and real people, not spin.
Days 60 through 90 cover the earned-coverage push and instrumentation. We pitch substantive stories to the appropriate outlets while tracking buyer-relevant reach and share of voice. Because PR is inherently ongoing, most engagements extend beyond the initial sprint as a standing motion aligned with your milestone calendar, while crisis infrastructure remains maintained throughout.
Our cadence includes a weekly working session with your marketing and leadership teams, along with rapid availability when a crisis occurs. Rather than parachuting in for isolated announcements, we remain embedded in your milestone calendar and risk posture, allowing credibility to compound.
- Coverage in buyer-trusted outlets
- Share of voice against competitors
- Established clinical credibility and validation
- Crisis readiness and contained incidents
If your diabetes & cardiometabolic health company needs public relations leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a public relations engagement cost for diabetes and cardiometabolic health companies?
We structure PR as a fixed monthly retainer, with the range based on the media push's intensity, the amount of credibility-building groundwork required, and whether crisis infrastructure must also be created from scratch. Since PR is an ongoing motion, most engagements continue beyond the initial sprint.
How soon will we see results from a public relations engagement?
A defined claims line and crisis readiness are established during the first 30 days, delivering immediate risk reduction. Earned coverage requires more time because credible placements depend on relationships and genuine milestones, so the first meaningful coverage usually appears within a few months.
How does the public relations team work with our current staff?
We integrate with your marketing, leadership, and clinical teams because credible health PR relies on real evidence and real people. Defining the claims line requires access to your clinical and legal teams, while your executives and clinical voices serve as spokespeople.
How is Winston Francois different from a conventional PR agency?
Traditional agencies pursue clips and consider compliance and crisis only afterward, which is how a win turns into an incident in a clinical category. We establish the claims line first, strengthen clinical credibility before the major announcement, and maintain crisis infrastructure throughout. We also evaluate coverage by whether it reaches your real buyers, rather than by the number of logos. In health, gaining attention and withstanding scrutiny are one job, and we manage them together.
How is ROI measured for a public relations engagement?
We evaluate coverage in outlets your buyers genuinely trust, share of voice relative to competitors, and whether the coverage advances sales conversations. Crisis preparedness and contained incidents also count as real returns, even if they are uncomfortable to quantify. We benchmark results against your credibility and coverage baseline before the engagement. We explicitly do not assess the work through vanity clip counts.
Which type of diabetes and cardiometabolic health company is best suited to this service?
This service suits companies with roughly 5M to 100M in ARR that have genuine milestones – clinical results, partnerships, meaningful traction – worthy of earned coverage, plus enough exposure to truly require a crisis plan. It is most effective when leadership commits to claiming no more than the evidence supports. If you lack near-term news and clinical substance, PR is premature, and your efforts are better directed toward building proof first. The process starts with a strategy call to map your milestone calendar and risk exposure.
